Frequently Asked Questions

Stem cell therapy for autism involves the administration of mesenchymal stem cells (MSCs), typically derived from umbilical cord tissue (Wharton's Jelly), to address biological factors associated with autism spectrum disorder. MSCs release anti-inflammatory molecules, growth factors, and exosomes that may help reduce neuroinflammation, modulate immune function, support gut health, and promote neural repair. It is an advanced intervention, not a cure.

UC-MSCs have a favorable safety profile documented in published studies. They are immunologically privileged and do not require donor matching. All our products undergo comprehensive testing for sterility, viability, potency, and genetic stability. As with any medical procedure, risks exist and are discussed thoroughly during consultation.

Results vary by individual. Some families report improvements in eye contact, language, social engagement, behavioral regulation, sleep, and GI function. We set realistic expectations and monitor progress systematically through our follow-up program. We never promise cures or guaranteed outcomes.

Stem cells are live cells that migrate to inflamed tissues and release therapeutic factors over time. Exosomes are concentrated nano-vesicles derived from stem cells that deliver rapid, targeted biological signals with superior blood-brain barrier penetration. We often combine both for comprehensive coverage.

We use mesenchymal stem cells derived from Wharton's Jelly (umbilical cord tissue), sourced from GMP-certified laboratories. These are ethically sourced from donated tissue following healthy births, extensively tested, and do not require donor-recipient matching.

Through intravenous (IV) infusion for systemic anti-inflammatory effects and/or intrathecal injection for direct CNS delivery. The optimal route is determined during your child's personalized treatment planning based on their specific clinical profile.

Yes. Some children benefit from additional sessions at intervals determined by response to initial treatment. Our follow-up monitoring program tracks progress and guides decisions about additional treatment.

Typically 5-7 days including initial assessments, treatment sessions, monitoring, and discharge consultation. Some families extend their stay for tourism or additional observation.

Costs depend on the specific protocol recommended. We provide transparent pricing during consultation. Istanbul offers significantly competitive pricing compared to Western alternatives — typically 50-70% less — reflecting favorable operational economics, not lower quality.

Yes. We welcome families from around the world with dedicated international patient support. Our team communicates fluently in English and assists with all aspects of medical travel.

We evaluate children on a case-by-case basis. Generally, children from age 2 and above may be considered, with earlier intervention potentially offering advantages due to greater neuroplasticity.

Yes. Our structured follow-up program includes video consultations at 1, 3, 6, and 12 months post-treatment, standardized outcome tracking, and ongoing access to our team for questions and concerns.

We recommend bringing medical records, developmental assessments, recent lab work, a list of medications, comfort items for your child, sensory support items, entertainment for waiting periods, and travel documents.

Requirements vary by country. Many nationalities can enter visa-free or obtain an e-Visa online. Our team provides visa guidance specific to your country of origin.

Yes. Our coordination team provides hotel recommendations, booking assistance, VIP airport transfers, and arranges all ground transportation during your stay.

Absolutely. We strongly encourage continuing speech therapy, OT, ABA, and other interventions alongside regenerative medicine. Our approach is complementary, not a replacement for established therapies.

Eligibility is determined through our consultation process, which includes a review of medical history, developmental profile, current health status, and any contraindications. Not every child is a candidate — we evaluate honestly and will not recommend treatment if it is not appropriate.

The gut-brain axis is the bidirectional communication pathway between the intestinal tract and the central nervous system. Approximately 90% of the body's serotonin is produced in the gut, meaning gut health directly affects mood, behavior, and brain function. Disruption of this pathway is common in autism and is a key target of our treatment approach.

Neuroinflammation is chronic inflammation within the brain and central nervous system, driven by persistently activated microglial cells. This inflammatory state can impair neural development, disrupt connectivity, and affect neurotransmitter production — contributing to many autism symptoms. It is one of our primary treatment targets.